Loading…
In person · Pittsburgh · PA · United States
Research provider: Pitt+Me
Do you have sleep apnea? If so, you may be eligible for a research study that’s using a new therapy plan called Rapid Multi-Modal Therapy (RMMT) to treat obstructive sleep apnea (OSA) and then see if successful treatment leads to improvement in blood markers of Alzheimer’s Disease risk, which might indicate a lower risk of developing Alzheimer's later in life. Compensation is provided.
Your total participation lasts about 2 years and consists of 4 key time points with multiple visits for each time point: The first time point consists of 3 baseline visits and involves completing an overnight sleep study, cognitive testing, and an optional MRI of your brain. You will then be randomized to immediate treatment where you will work with physicians to find the best treatment for your sleep apnea, or you will be assigned to wait 3-months until you get your treatment. For the third time point, 3 months after baseline or successful treatment, we will ask you to come back and do an overnight sleep study and cognitive testing. At the one-year time point, a short follow-up visit is requested so we can update your health information and repeat cognitive testing. The final two-year time point consists of 2 follow-up visits and involves an overnight sleep study, cognitive testing, and interview with a clinician on the study.
Do you have sleep apnea? If so, you may be eligible for a research study that’s using a new therapy plan called Rapid Multi-Modal Therapy (RMMT) to treat obstructive sleep apnea (OSA) and then see if successful treatment leads to improvement in blood markers of Alzheimer’s Disease risk, which might indicate a lower risk of developing Alzheimer's later in life. Compensation is provided.
Review the provider’s screening questions. These requirements do not guarantee selection.